Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Explore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial)

NCT03244319 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT03244319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03244319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Explore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial)
Lead sponsor
Yonsei University
Phase
Phase 3
Overall status
Completed
Start date
December 1, 2017
Completion date
September 30, 2019
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mv(mitral valve) repair